In line, the knockdown of CDC20 is a promising approach in treating different cancers, including lung [69], prostate [36], colorectal [70], hepatocellular carcinoma [71], and gastric cancers [72], as well as many other types. The gene discussed is CDC20; the disease is gastric cancer.